EFFECT OF EVEROLIMUS INTRODUCTION AND CALCINEURIN INHIBITOR REDUCTION ON GRAFT VASCULOPATHY IN HEART TRANSPLANT RECIPIENTS

被引：0

作者：

Arora, Satish ^{[1
]}

Wennerblom, Bertil ^{[1
]}

Rundqvist, Bengt ^{[1
]}

Eiskjaer, Hans ^{[1
]}

Botker, Hans ^{[1
]}

Mortensen, Svend Aage ^{[1
]}

Saunameki, Kari ^{[1
]}

Ekmehag, Bjorn ^{[1
]}

Janssson, Kjell ^{[1
]}

Simonsen, Svein ^{[1
]}

Gude, Einar ^{[1
]}

Endresen, Knut ^{[1
]}

Solbu, Dag ^{[1
]}

Gullestad, Lars ^{[1
]}

机构：

[1] Natl Hosp Norway, Oslo Univ Hosp, Oslo, Norway

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2010年 / 55卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A19.E177

引用

页数：1

共 50 条

[31] Evaluation of graft vasculopathy with intravascular ultrasonography in pediatric heart transplant recipients
Balzer, DT
Canter, CE
[J]. CIRCULATION, 1996, 94 (08) : 3812 - 3812
[32] A Randomized Trial of Everolimus Initiation and Calcineurin Inhibitor (CNI) Elimination in Stable Heart Transplant Recipients With Impaired Renal Function
Derthoo, D.
Van Caenegem, O.
De Pauw, M.
Nellessen, E.
Duerinckx, N.
Ciarka, A.
Droogne, W.
Van Cleemput, J.
Belmans, A.
Meyns, B.
Vanhaecke, J.
[J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S14 - S14
[33] Conversion to Everolimus-Based Immunosuppression Regimen with Calcineurin Inhibitor Reduction Ameliorates Histological Damage in Kidney Transplant Recipients with Calcineurin Inhibitor-Induced Nephrotoxicity.
Hotta, K.
Iwahara, N.
Tanabe, T.
Shinohara, N.
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1083 - 1083
[34] Free calcineurin inhibitor regimen is effective and safe in heart transplant recipients
Rabago, Gregorio
Lage, Ernesto
Crespo, Marisa
Manito, Nicolas
Delgado, Juan
Gonzalez-Vilchez, Francisco
Segovia, Javier
Perez-Villa, Felix
Camprecios, Marta
Palomo, Jess
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 349 - 349
[35] Effect of oral vitamin E and C therapy on calcineurin inhibitor levels in heart transplant recipients
Lake, KD
Aaronson, KD
Gorman, LE
Pagani, FD
Koelling, TM
[J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (08): : 990 - 994
[36] Everolimus as a Calcineurin Inhibitor-Sparing Immunosuppressive Agent in Lung Transplant Recipients With Renal Impairment
Yo, Shaun
Coughlan, Tim
Ivulich, Steve
Paul, Eldho
Snell, Gregory
Menahem, Solomon
[J]. CHEST, 2017, 152 (04) : 1098A - 1098A
[37] Everolimus With Reduced Calcineurin Inhibitor in Thoracic Transplant Recipients With Renal Dysfunction: A Multicenter, Randomized Trial
Gullestad, Lars
Iversen, Martin
Mortensen, Svend-Aage
Eiskjaer, Hans
Riise, Gerdt C.
Mared, Lena
Bjortuft, Oystein
Ekmehag, Bjorn
Jansson, Kjell
Simonsen, Svein
Gude, Einar
Rundqvist, Bengt
Fagertun, Hans E.
Solbu, Dag
Bergh, Claes-Hakan
[J]. TRANSPLANTATION, 2010, 89 (07) : 864 - 872
[38] Virtual Fractional Flow Reserve in Heart Transplant Recipients with and without Graft Vasculopathy
Nagumo, S.
Gallinoro, E.
Candreva, A.
Mizukami, T.
Verstreken, S.
Dierckx, R.
Heggermont, W.
Bartunek, J.
de Bruyne, B.
Sonck, J.
Collet, C.
Vanderheyden, M.
[J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S76 - S77
[39] Effects of everolimus conversion from mycophenolate mofetil on cardiac allograft vasculopathy in heart transplant recipients
Watanabe, T.
Murata, Y.
Hieda, M.
Sunami, H.
Nishimura, K.
Miyamoto, Y.
Sato, T.
Seguchi, O.
Yanase, M.
Nakatani, T.
[J]. EUROPEAN HEART JOURNAL, 2013, 34 : 1064 - 1064
[40] BOOP is common in heart transplant recipients switched from a calcineurin inhibitor to sirolimus
Lindenfed, J
Shakar, S
Zamora, M
Cool, C
Wolfel, EE
Lowes, BD
Ireland, N
Keller, K
Stepien, L
Frisk, R
Rohrbough, L
Cleveland, J
[J]. CIRCULATION, 2004, 110 (17) : 584 - 584

← 1 2 3 4 5 →